Literature DB >> 25755560

Immortalization of Human Fetal Hepatocyte by Ectopic Expression of Human Telomerase Reverse Transcriptase, Human Papilloma Virus (E7) and Simian Virus 40 Large T (SV40 T) Antigen Towards Bioartificial Liver Support.

Shibashish Giri1, Augustinus Bader1.   

Abstract

BACKGROUND: Generation of genetically stable and non-tumoric immortalization cell line from primary cells would be enormously useful for research and therapeutic purposes, but progress towards this goal has so far been limited. It is now universal acceptance that immortalization of human fetal hepatocytes based on recent advances of telomerase biology and oncogene, lead to unlimited population doubling could be the possible source for bioartificial liver device.
METHODS: Immortalization of human fetal hepatocytes cell line by ectopic expression of human telomerase reverse transcriptase (hTERT), human papilloma virus gene (E7) and simian virus 40 large T (SV40 T) antigens is main goal of present study. We used an inducible system containing human telomerase and E7, both of which are cloned into responder constructs controlled by doxycycline transactivator. We characterized the immortalized human fetal hepatocyte cells by analysis of green fluorescent cells (GFP) positive cells using flow cytometry (FACs) cell sorting and morphology, proliferative rate and antigen expression by immunohistochemical analysis. In addition to we analysized lactate formation, glucose consumption, albumin secretion and urea production of immortalized human fetal hepatocyte cells.
RESULTS: After 25 attempts for transfection of adult primary hepatocytes by human telomerase and E7 to immortalize them, none of the transfection systems resulted in the production of a stable, proliferating cell line. Although the transfection efficiency was more than 70% on the first day, the vast majority of the transfected hepatocytes lost their signal within the first 5-7 days. The remaining transfected hepatocytes persisted for 2-4 weeks and divided one or two times without forming a clone. After 10 attempts of transfection human fetal hepatocytes using the same transfection system, we obtained one stable human fetal hepatocytes cell line which was able albumin secretion urea production and glucose consumption.
CONCLUSION: We established a conditional human fetal hepatocytes cell line with mesenchymal characteristics. Thus immortalization of human fetal hepatocytes cell line by telomerase biology offers a great challenge to examine basic biological mechanisms which are directly related to human and best cell source having unlimited population doubling for bioartificial support without any risk of replicative senescence and pathogenic risks.

Entities:  

Keywords:  AFP, alpha-fetoprotein; BLD, bioartificail liver device; E7; E7, human papilloma virus; EBV, epstein barr virus; EGFP, enhanced green fluorescent protein; FACs, flow cytometry; FH, fetal hepatocytes; GFP, green fluorescent cells positive cells; HPV, human papilloma virus; SV T 40 antigen; SV40 T, simian virus 40 large T; bioartificial liver device; hTERT; hTERT, human telomerase reverse transcriptase; human fetal hepatocytes; iPS, pluripotent stem cell

Year:  2014        PMID: 25755560      PMCID: PMC4284290          DOI: 10.1016/j.jceh.2014.08.001

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  43 in total

1.  Telomerase induces immortalization of human esophageal keratinocytes without p16INK4a inactivation.

Authors:  Hideki Harada; Hiroshi Nakagawa; Kenji Oyama; Munenori Takaoka; Claudia D Andl; Birgit Jacobmeier; Alexander von Werder; Gregory H Enders; Oliver G Opitz; Anil K Rustgi
Journal:  Mol Cancer Res       Date:  2003-08       Impact factor: 5.852

2.  Cryopreservation of adult human hepatocytes obtained from resected liver biopsies.

Authors:  E Alexandre; C Viollon-Abadie; P David; A Gandillet; P Coassolo; B Heyd; G Mantion; P Wolf; P Bachellier; D Jaeck; L Richert
Journal:  Cryobiology       Date:  2002-04       Impact factor: 2.487

3.  Telomerase activity does not always imply telomere maintenance.

Authors:  M M Ouellette; D L Aisner; I Savre-Train; W E Wright; J W Shay
Journal:  Biochem Biophys Res Commun       Date:  1999-01-27       Impact factor: 3.575

4.  Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure.

Authors:  A J Ellis; R D Hughes; J A Wendon; J Dunne; P G Langley; J H Kelly; G T Gislason; N L Sussman; R Williams
Journal:  Hepatology       Date:  1996-12       Impact factor: 17.425

5.  Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial.

Authors:  F D Watanabe; C J Mullon; W R Hewitt; N Arkadopoulos; E Kahaku; S Eguchi; T Khalili; W Arnaout; C R Shackleton; J Rozga; B Solomon; A A Demetriou
Journal:  Ann Surg       Date:  1997-05       Impact factor: 12.969

6.  hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization.

Authors:  M Meyerson; C M Counter; E N Eaton; L W Ellisen; P Steiner; S D Caddle; L Ziaugra; R L Beijersbergen; M J Davidoff; Q Liu; S Bacchetti; D A Haber; R A Weinberg
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

7.  Human endothelial cell life extension by telomerase expression.

Authors:  J Yang; E Chang; A M Cherry; C D Bangs; Y Oei; A Bodnar; A Bronstein; C P Chiu; G S Herron
Journal:  J Biol Chem       Date:  1999-09-10       Impact factor: 5.157

8.  Reverse transcriptase motifs in the catalytic subunit of telomerase.

Authors:  J Lingner; T R Hughes; A Shevchenko; M Mann; V Lundblad; T R Cech
Journal:  Science       Date:  1997-04-25       Impact factor: 47.728

9.  Immortalisation of human ovarian surface epithelium with telomerase and temperature-sensitive SV40 large T antigen.

Authors:  Barry R Davies; Islay A Steele; Richard J Edmondson; Simon A Zwolinski; Gabriele Saretzki; Thomas von Zglinicki; Michael J O'Hare
Journal:  Exp Cell Res       Date:  2003-08-15       Impact factor: 3.905

10.  Porcine endogenous retrovirus released by a bioartificial liver infects primary human cells.

Authors:  Jan-Henning Frühauf; Heike Mertsching; Shibashish Giri; Nils Roman Frühauf; Augustinus Bader
Journal:  Liver Int       Date:  2009-08-14       Impact factor: 5.828

View more
  2 in total

1.  Immortalized common marmoset (Callithrix jacchus) hepatic progenitor cells possess bipotentiality in vitro and in vivo.

Authors:  Zhenglong Guo; Renwei Jing; Quan Rao; Ludi Zhang; Yimeng Gao; Fengyong Liu; Xin Wang; Lijian Hui; HaiFang Yin
Journal:  Cell Discov       Date:  2018-05-15       Impact factor: 10.849

2.  Primary-like Human Hepatocytes Genetically Engineered to Obtain Proliferation Competence as a Capable Application for Energy Metabolism Experiments in In Vitro Oncologic Liver Models.

Authors:  Andrea Scheffschick; Jonas Babel; Sebastian Sperling; Julia Nerusch; Natalie Herzog; Daniel Seehofer; Georg Damm
Journal:  Biology (Basel)       Date:  2022-08-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.